European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia

INDIANAPOLIS, Oct. 24 /PRNewswire-FirstCall/ — The Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a negative opinion on a Cymbalta application for the treatment of …

Read full story

Share

No related posts.

Leave a Reply

Spam Protection by WP-SpamFree



Subscribe without commenting


Advertisement
Donate to Us

Have we helped or inspired YOU today?

Subscribe by RSS
Subscribe by Email:
Delivered by FeedBurner
February 2012
MTWTFSS
« Jan  
 12345
6789101112
13141516171819
20212223242526
272829 


Page 1 of 11

Page optimized by WP Minify WordPress Plugin